SE8901115D0 - Biologiskt aktiva proteiner - Google Patents

Biologiskt aktiva proteiner

Info

Publication number
SE8901115D0
SE8901115D0 SE8901115A SE8901115A SE8901115D0 SE 8901115 D0 SE8901115 D0 SE 8901115D0 SE 8901115 A SE8901115 A SE 8901115A SE 8901115 A SE8901115 A SE 8901115A SE 8901115 D0 SE8901115 D0 SE 8901115D0
Authority
SE
Sweden
Prior art keywords
biologically active
active proteins
proteins
febule
tnf
Prior art date
Application number
SE8901115A
Other languages
English (en)
Other versions
SE8901115L (sv
Inventor
J-M Dayer
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8901115D0 publication Critical patent/SE8901115D0/sv
Publication of SE8901115L publication Critical patent/SE8901115L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8901115A 1988-03-31 1989-03-30 Biologiskt aktiva proteiner SE8901115L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807803A GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product

Publications (2)

Publication Number Publication Date
SE8901115D0 true SE8901115D0 (sv) 1989-03-30
SE8901115L SE8901115L (sv) 1989-10-01

Family

ID=10634493

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901115A SE8901115L (sv) 1988-03-31 1989-03-30 Biologiskt aktiva proteiner

Country Status (12)

Country Link
JP (1) JPH02117700A (sv)
KR (1) KR890014125A (sv)
AU (1) AU3228789A (sv)
BE (1) BE1001845A4 (sv)
DE (1) DE3910323A1 (sv)
DK (1) DK156589A (sv)
FR (1) FR2629345A1 (sv)
GB (2) GB8807803D0 (sv)
IL (1) IL89804A0 (sv)
IT (1) IT1232827B (sv)
NL (1) NL8900779A (sv)
SE (1) SE8901115L (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5811261A (en) * 1988-09-12 1998-09-22 Yeda Research And Development Co. Ltd. Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
ATE289350T1 (de) 1989-04-21 2005-03-15 Amgen Inc Tnf-rezeptor, tnf bindende proteine und dafür kodierende dnas
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
IL95031A (en) * 1989-07-18 2007-03-08 Amgen Inc A method of producing a recombinant human necrotic factor absorber
US5945397A (en) * 1989-09-05 1999-08-31 Immunex Corporation Purified p75 (type II) tumor necrosis factor receptor polypeptides
AU630497B2 (en) * 1989-09-05 1992-10-29 Immunex Corporation Tumor necrosis factor-alpha and -beta receptors
US5605690A (en) * 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
EP1132471A3 (de) 1989-09-12 2001-11-28 F. Hoffmann-La Roche Ag TNF-bindende Proteine
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1992001002A1 (fr) * 1990-07-11 1992-01-23 Teijin Limited Inhibiteur de l'activite du facteur de la necrose tumorale et son procede de preparation
EP0480389A1 (de) * 1990-10-12 1992-04-15 Hoechst Aktiengesellschaft Inhibitoren für die Bildung von Tumor Nekrose Faktor, Verfahren zu deren Herstellung und deren Verwendung
JP2864434B2 (ja) * 1991-01-18 1999-03-03 サイナーゲン，インコーポレーテッド 腫瘍壊死因子媒介疾患の治療方法
WO1993004375A1 (en) * 1991-08-23 1993-03-04 Nchip, Inc. Burn-in technologies for unpackaged integrated circuits
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
ATE406176T1 (de) 1996-12-06 2008-09-15 Amgen Inc Il-1-inhibitor in kombinationstherapie zur behandlung il-1-vermittelter krankheiten
ATE247974T1 (de) 1996-12-06 2003-09-15 Amgen Inc Kombinationtherapie mit einem tnf-bindendem protein zür behandlung von durch tnf verursachten erkrangungen
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
PT2087908T (pt) 2001-06-26 2018-07-16 Amgen Inc Anticorpos contra opgl
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
JP2006517191A (ja) 2002-12-30 2006-07-20 アムジエン・インコーポレーテツド 共刺激因子を用いた併用療法
US7767206B2 (en) 2006-10-02 2010-08-03 Amgen Inc. Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
PL2523688T3 (pl) 2010-01-15 2018-04-30 Kirin-Amgen, Inc. Formulacja przeciwciała i reżimy terapeutyczne
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
EP3126392B1 (en) 2014-03-31 2019-09-11 Kirin-Amgen, Inc. Methods of treating nail and scalp psoriasis

Also Published As

Publication number Publication date
BE1001845A4 (fr) 1990-03-20
IT1232827B (it) 1992-03-05
IT8947794A0 (it) 1989-03-30
SE8901115L (sv) 1989-10-01
JPH02117700A (ja) 1990-05-02
NL8900779A (nl) 1989-10-16
DK156589A (da) 1989-10-01
GB2218101A (en) 1989-11-08
KR890014125A (ko) 1989-10-21
DE3910323A1 (de) 1989-10-19
AU3228789A (en) 1989-10-05
DK156589D0 (da) 1989-03-30
IL89804A0 (en) 1989-09-28
GB8907148D0 (en) 1989-05-10
FR2629345A1 (fr) 1989-10-06
GB8807803D0 (en) 1988-05-05

Similar Documents

Publication Publication Date Title
SE8901115L (sv) Biologiskt aktiva proteiner
FI99015B (sv) Förfarande för framställning av ett biologiskt aktivt mutein av tumörnekrosisfaktor-proteinet
IT8547835A0 (it) Procedimento di purificazione di proteine ossee
DE69008423D1 (de) Dynamische Fixierung von Schweinsaortaklappen.
IT8467249A0 (it) Protesi valvolare cardiaca provvista di lembi valvolari di tessuto biologico
DE3587549D1 (de) Ergänzungstestverfahren von proteine bindenden enzymen.
DE3683318D1 (de) Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege.
DK1394179T3 (da) Fremgangsmåde til fremstilling af erythropoietin fri for animalske proteiner
EA200000311A1 (ru) Новый белок иммунной системы - кау
DE3581407D1 (de) Bewahrung lebender gewebe.
DK31088D0 (da) Blodkoaguleringsnedsaettende peptidderivater
NO178682C (no) Fremgangsmåte for å stabilisere blodkoagulasjonsfaktorer, samt kontrollplasma og reagens for å bestemme biologisk aktivitet av blodkoagulasjonsfaktorer
DE68915715D1 (de) Membran-Blutoxygenator.
DE3650135T2 (de) Proteingewinnung.
DK235687A (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
DE3686130D1 (de) Geschmackskontrolle von proteinhydrolysaten.
DE68917324T2 (de) Methode zur Immobilisierung von physiologisch aktiven Substanzen.
DE69822164D1 (de) Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
DE68908046D1 (de) Instrument fuer inokulation von zwiebelschalen.
ATE70453T1 (de) Verwendung von interleukin-1-proteinen gegen arthritis.
NO864301D0 (no) Dna-prober for human regulatorisk enhet av camp-avhengige proteinkinaser.
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
KR910006478A (ko) 인체 트립타제 유사 단백질
EP0239644A4 (en) NEW PHYSIOLOGICALLY ACTIVE AGENTS WITH A BLOOD COAGULATING REGULATORY EFFECT.
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8901115-9

Effective date: 19910424